Published in Lipids Health Dis on April 27, 2016
Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest (2004) 13.42
Liver regeneration. J Hepatol (2000) 5.22
Prevalence of the metabolic syndrome and overweight among adults in China. Lancet (2005) 5.05
Fatty liver: a novel component of the metabolic syndrome. Arterioscler Thromb Vasc Biol (2007) 3.83
Fatty liver in type 2 diabetes mellitus: relation to regional adiposity, fatty acids, and insulin resistance. Am J Physiol Endocrinol Metab (2003) 2.56
Newly diagnosed diabetes mellitus as a risk factor for serious liver disease. CMAJ (2010) 1.95
Hepatocarcinogenesis: a dynamic cellular perspective. Lab Invest (1987) 1.82
Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J Cancer Res Clin Oncol (2004) 1.75
beta-cell dysfunction and failure in type 2 diabetes: potential mechanisms. Diabetes (2001) 1.74
Roles for chemokines in liver disease. Gastroenterology (2014) 1.59
High-carbohydrate, high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol (2011) 1.31
Insulin resistance in obesity as the underlying cause for the metabolic syndrome. Mt Sinai J Med (2010) 1.29
Liver regeneration and alpha-fetoprotein messenger RNA expression in the retrorsine model for hepatocyte transplantation. Cancer Res (1998) 1.24
The metabolic syndrome: the crossroads of diet and genetics. Proc Nutr Soc (2005) 1.23
Metabolic syndrome, aging and involvement of oxidative stress. Aging Dis (2015) 1.22
Serological markers of liver cancer. Best Pract Res Clin Gastroenterol (2005) 1.17
Oxidative stress and metabolic disorders: Pathogenesis and therapeutic strategies. Life Sci (2016) 1.15
Expression of an oncodevelopmental gene product (alpha-fetoprotein) during fetal development and adult oncogenesis. Cancer Res (1976) 1.12
Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats. Exp Diabetes Res (2011) 1.09
alpha-fetoprotein in noneoplastic hepatic disorders. JAMA (1975) 1.09
Serum alpha-fetoprotein levels in patients with chronic hepatitis C. Relationships with serum alanine aminotransferase values, histologic activity index, and hepatocyte MIB-1 scores. Am J Clin Pathol (1999) 1.04
Pluripotential liver stem cells: facultative stem cells located in the biliary tree. Cell Prolif (1996) 1.04
Hepatic progenitor cells, stem cells, and AFP expression in models of liver injury. Int J Exp Pathol (2006) 1.01
Serum alpha-fetoprotein and its lectin reactivity in liver diseases: a review. Ann Clin Lab Sci (1990) 1.01
Epigenomics, gestational programming and risk of metabolic syndrome. Int J Obes (Lond) (2015) 0.99
Insulin resistance increases the occurrence of new cardiovascular events in patients with manifest arterial disease without known diabetes. the SMART study. Cardiovasc Diabetol (2011) 0.99
Serum α-fetoprotein levels in liver steatosis. Hepatol Int (2009) 0.94
Hepatic Steatosis as a Marker of Metabolic Dysfunction. Nutrients (2015) 0.92
Alpha-fetoprotein: a review. Crit Rev Clin Lab Sci (1981) 0.91
Is AFP a new reliable marker of liver regeneration in acute hepatic failure? J Gastroenterol (2002) 0.87
Effectiveness of different waist circumference cut-off values in predicting metabolic syndrome prevalence and risk factors in adults in China. Biomed Environ Sci (2014) 0.86
Hepatocellular carcinoma (HCC) and diagnostic significance of A-fetoprotein (AFP). J Ayub Med Coll Abbottabad (2010) 0.85
Clinical characteristics of metabolic syndrome in Korea, and its comparison with other Asian countries. J Diabetes Investig (2015) 0.84
Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans. Dig Dis Sci (2007) 0.84
Metabolic Syndrome: Insulin Resistance and Prediabetes. FP Essent (2015) 0.82
Metabolic Syndrome: Nonalcoholic Fatty Liver Disease. FP Essent (2015) 0.81
Association between serum alpha-fetoprotein levels and fatty liver disease: a cross-sectional study. World J Gastroenterol (2014) 0.81
Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders. Clin Liver Dis (2015) 0.80
Molecular mechanisms involved in hepatic steatosis and insulin resistance. J Diabetes Investig (2011) 0.79
Risk of major adverse cardiovascular events in patients with metabolic syndrome after revascularization: A meta-analysis of eighteen cohorts with 18,457 patients. Metabolism (2015) 0.78
Stimulation of oval cell and hepatocyte proliferation by exogenous bombesin and neurotensin in partially hepatectomized rats. World J Gastrointest Pathophysiol (2011) 0.77
The clinical significance of human alpha-fetoprotein. Ann Clin Lab Sci (1978) 0.77
Unique features associated with hepatic oxidative DNA damage and DNA methylation in non-alcoholic fatty liver disease. J Gastroenterol Hepatol (2016) 0.77
Metabolic syndrome: evidences for a personalized nutrition. Mol Nutr Food Res (2011) 0.76
Metabolic Syndrome: Hyperlipidemia. FP Essent (2015) 0.76